Rentabilidad en el año
| Fondo | Fecha | |||||
|---|---|---|---|---|---|---|
| 2025 | ||||||
| Resultados por página: 10 | 20 | 50 | 100Se muestran de 331 a 340 de un total de 37468 fondos | ||||||
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | 31/10 | 36,39% | ||||
| GCO ACCIONES, FI | 28/10 | 36,33% | ||||
| BNY MELLON BRAZIL EQUITY FUND EURO A (ACC) | 31/10 | 36,32% | ||||
| CT (LUX) GLOBAL TECHNOLOGY AEH EUR | 31/10 | 36,25% | ||||
| LO FUNDS - EMERGING HIGH CONVICTION SYST. NAV HDG (CHF) N CAP | 30/10 | 36,22% | ||||
| GOLDMAN SACHS GREATER CHINA EQUITY R CAP USD | 31/10 | 36,15% | ||||
| GOLDMAN SACHS GREATER CHINA EQUITY R DIS USD | 31/10 | 36,15% | ||||
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) (EUR HEDGED) P-ACC | 30/10 | 36,11% | ||||
| AXA WORLD FUNDS-AI & METAVERSE G CAP EUR HEDGED | 31/10 | 36,10% | ||||
| DWS INVEST BRAZILIAN EQUITIES FC | 31/10 | 36,04% | ||||
